Bionano Genomics (NASDAQ: BNGO) participated in the Association for Molecular Pathology (AMP) Annual Meeting, held November 11-15, 2025 in Boston, MA. Key presentations at the conference highlighted ...
Bionano Genomics lud am 13.11.2025 zur turnusmäßigen Finanzkonferenz und hat dort das Zahlenwerk zum jüngsten Quartal veröffentlicht, das am 30.09.2025 endete. Dabei wurde ein Verlust je Aktie von ...
Bionano Genomics, Inc. (NASDAQ:BNGO) Q3 2025 Earnings Call Transcript November 13, 2025 Bionano Genomics, Inc. beats earnings expectations. Reported EPS is $-1.59292, expectations were $-1.81.
Total Revenue: $7.4 million for Q3 2025, a 21% increase compared to Q3 2024. Core Revenue Growth: 12% year-over-year increase in Q3 2025, adjusting for a $0.5 million write-down in 2024. Flow Cells ...
Total Revenue-- $7.4 million in 2025, a 21% increase over 2024, with core revenue up 12% after adjusting for a $500,000 write-down in discontinued clinical services in 2024. Flow Cells Sold-- 8,390 ...
Bionano’s technology aims to consolidate traditional cytogenetics methods into a single digital platform for structural variant detection and analysis, positioning the company at the intersection of ...
Bionano Genomics reported a solid performance in Q3 2025, with a 21% year-over-year increase in revenue, reaching $7.4 million. Despite a challenging market environment, the company’s stock closed at ...
Bionano Genomics veröffentlicht am 13.11.2025 auf der all-dreimonatlichen Finanzkonferenz die Zahlen zum am 30.09.2025 abgelaufenen Jahresviertel. Im Schnitt gehen 2 Analysten von einem Verlust von -2 ...
Based on the one-year price targets offered by 2 analysts, the average target price for Bionano Genomics Inc (NASDAQ:BNGO) is $9.50 with a high estimate of $11.00 and a low estimate of $8.00. The ...
Bionano Genomics: Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress
SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the third quarter ended September 30, 2025. "Over the last year, we have taken ...
Bionano Genomics, Inc. (NASDAQ:BNGO) is among the best fundamentally strong penny stocks to buy right now. Bionano Genomics, Inc. (NASDAQ:BNGO) has launched a public offering of 5 million shares, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback